Neurology Center

The Neurology Center of Beijing Tiantan Hospital, Capital Medical University ("Neurology Center") was established in 1980. After nearly 40 years of unremitting efforts of several generations, the center has been steadily developing. It has more than 300 beds and a daily outpatient volume of almost 1,300, making it one of China's largest and most complete neurology departments. In the past 20 years of development, the Neurology Center, under the leadership of the leading figure of the discipline, Professor Yongjun Wang, Director of the Neurology Branch of the Chinese Medical Association and Executive Vice President of the hospital, and Professor Xingquan Zhao, the leader of the Neurology Center, has constantly been innovating  and forging ahead with the tenet of "serving people's health" and the core value of "patient first." Especially in recent years, it has made rapid development in medical work, technical level, scientific research, talent cultivating, teaching, education, etc. As a result, it has outstanding achievements in medical education and research. As a result, it has a first-class influence on the discipline in China.

The center has strived to promote the rapid development of high-quality neurology subspecialties. The Party Committee of the hospital has been far-sighted and coordinated to improve the construction of discipline groups according to the requirements of the structure of secondary disciplines since 2014. It has established "The Department of Vascular Neurology," "Neurointensive Care Unit, Department of Neurology" "The Department of Movement Disorders," "The Department of Epilepsy," "The Department of Neuroinfection and Immunity Diseases," "The Department of Cognitive Disorders" and "The Department of Headache," a totally eight subspecialty departments.

"The Department of Vascular Neurology is the advantageous department of the Neurology Center and was the first to establish the first stroke unit and cerebrovascular disease outpatient clinic with international standards in China. After nearly 20 years of development, under the leadership of President Yongjun Wang, Professor Xingquan Zhao,  Director of the Neurology Center and Director of the Vascular Neurology Department, has integrated the Vascular Neurology Department with neurosurgery, neuro intervention, neuroimaging, testing, and emergency medicine to establish a green treatment channel for acute cerebrovascular diseases, forming an advanced multidisciplinary treatment model for cerebrovascular diseases in China and providing one-stop services for patients with cerebrovascular diseases. The advanced organized medical service not only further reduces the mortality and disability rate of patients but also effectively shortens the hospitalization time of patients, reduces the treatment cost of patients, and achieves good social and economic benefits.

The Department of Vascular Neurology is driven by clinical research. It has established a national clinical research network and a big data platform for clinical research on cerebrovascular diseases, especially the multicenter, randomized, double-blind, parallel-controlled study of clopidogrel in combination with aspirin versus aspirin alone for the treatment of people at high risk of acute non-disabling cerebrovascular events (referred to as the CHANCE study) under the leadership of Professor Yongjun Wang, published in 2013 in The CHANCE study was published in the New England Journal in 2013, rewriting clinical guidelines for acute stroke and secondary prevention of cerebrovascular disease in the US, Canada, UK, and China. He has become the world's number one scholar in cerebrovascular disease (stroke and transient ischemic attack research topics) regarding the number of publications and total citations in the past five years.

In recent years, the Department of Vascular Neurology has been selected as a national key discipline by the Ministry of Education, a national clinical key specialty by the Ministry of Health, a research innovation team for cerebrovascular disease prevention and treatment by the Ministry of Science and Technology, a medical quality control team for cerebrovascular disease by the National Health Commission, and the establishment of a first-level society in the field of cerebrovascular disease. In addition, the "Chinese Stroke Association" founded the Tiantan International Cerebrovascular Disease Conference, which has been successfully held 19 times, striving to make more significant contributions to the prevention and control of cerebrovascular disease in China!

"Neurointensive Care Unit, Department of Neurology" specializes in the monitoring and management of acute and severe neurological diseases and takes advantage of the multidisciplinary integrated management model, focusing on acute and severe cerebrovascular diseases, including ischemic stroke revascularization treatment, acute treatment of hemorrhagic cerebrovascular disease; severe neurological infectious, immune diseases; persistent status epilepticus; acute neurological infectious diseases; and acute neurological diseases; persistent status epilepticus; urgent maternal care. Equipped with domestic first-class multi-system monitoring and rescue equipment and advanced treatment technology, the hospital focuses on the advantages of multi-modal neurological function assessment, integrates multidisciplinary key technologies, builds a non-invasive dynamic assessment platform for cerebral blood flow, cerebral electrophysiology, intracranial pressure, cerebral metabolism, and hemodynamics, and establishes a system for monitoring and treatment of acute and severe cerebrovascular diseases, a green channel for the treatment of severely ill pregnant women with combined central nervous system diseases, and a hospital-wide platform for the treatment of neurological disorders. It has organized a six-month training program for the backbone of the National Neurocritical Care Physicians Workshop, which has been well received by colleagues nationwide for its training of excellent neurocritical care specialists from clinical and scientific research perspectives.

"The Department of Movement Disorders" is the first center in China to focus on Parkinson's disease, related movement disorders, and brain atrophy as the main scope of diagnosis, treatment, and clinical research. It is the initiator and prominent director of the China Parkinson's Alliance and China Neuromodulation Alliance, which set the clinical diagnosis and quality index of Parkinson's disease in China. In addition, the medical team of this specialty was selected as one of the first famous expert teams in Beijing, and the nursing team of this specialty was selected as one of the first nursing studios in Beijing.

Since its establishment, the department has been awarded the title of Advanced Department of Beijing Tiantan Hospital for three consecutive years and the title of Hospital-level Youth Civilization. The team adheres to humanistic care and professionalism, applies advanced medical concepts and technologies nationally and internationally, implements high-level clinical treatment pathways and standardized treatment procedures, and strives to provide patients with precise medical services that meet their conditions and individual needs.

The "Department of Epilepsy" was established based on the Epilepsy Specialty Group of the Department of Neurology. Together with the Epilepsy Surgery Department, it forms the Epilepsy Center of Beijing Tiantan Hospital. It is the location of the Beijing Epilepsy Difficult Disease Consultation Center, part of the National Clinical Research Center for Neurological Diseases, the first batch of the Comprehensive Epilepsy Center and EEG Training Base of China Anti-Epilepsy Association.

The epilepsy clinic includes epilepsy genetics, co-morbidities, rational drug use, neuromodulation, and preoperative evaluation clinics. Main specialties: epilepsy and other seizure disorders, such as seizure convulsions, abnormal sensation, fainting, syncope, short-term loss of consciousness, involuntary movements, mental abnormalities, and sleep disorders.

Based on standardized medical diagnosis and treatment, the epilepsy ward will carry out a ketogenic diet treatment program for clinically refractory epilepsy based on regular antiepileptic drug treatment with an expert group composed of pediatrics and clinical nutrition; and implement a surgical treatment program with a talented group consisting of functional neurosurgery for a comprehensive evaluation to improve the control rate of clinical seizures further and improve the quality of life of patients.

"The Department of Neurological Infectious and Immune Diseases" has been dedicated to diagnosing and treating autoimmune diseases and infectious diseases of the central nervous system since its establishment in 2001. It has participated in developing the Chinese expert consensus on multiple sclerosis and optic neuromyelitis optica. In 2018, we jointly established Beijing and Tianjin Neuroimmune Collaborative Center with the Department of Neurology of Tianjin Medical University General Hospital, which is dedicated to promoting the establishment of standardized diagnosis and treatment procedures and laboratory diagnostic standards for CNS autoimmune diseases nationwide.

"The Department of Neurological Infectious and Immune Diseases" has a general outpatient clinic, a specialized outpatient clinic, a special needs clinic, a consultation for complicated diseases, and an international medical department. The team has established a good collaboration with neurosurgery, ophthalmology, blood transfusion, neuroimaging, and other related clinical departments to provide the most advanced diagnosis and treatment concepts for patients with neuroimmune and infectious diseases nationwide with an international perspective and to give the patients high-level and comprehensive medical services.

"The Department of Neuromuscular Disease" focuses on diagnosing and treating peripheral neuropathies, muscular diseases, cerebral leukodystrophies, and genetic neurological diseases.

The Department of Neuromuscular Disease consists of a neuromuscular disease group, a neuromuscular electrophysiology group, and a neuroprosthetic group. The main supporting laboratories and institutions include the neuromuscular electrophysiology examination room, the neuromuscular pathology laboratory, the molecular genetic disease diagnosis laboratory of the National Clinical Research Center for Neurological Diseases, the ultrastructural research laboratory of the Institute of Neurosurgery, neuro electrophysiology research laboratory, and nerve injury repair center. Scientific research projects are supported by national key special projects and major projects of the capital city.

"The Department of Cognitive Disorders" is a specialized center that focuses on diagnosing and treating Alzheimer's disease, vascular dementia, and other cognitive disorders and clinical research. It includes a cognitive disorders outpatient clinic, a neuropsychological scale assessment room, and a cognitive disorders ward.

The Department of Cognitive Disorders has a team of international and domestic experts and scholars and a first-class nursing team who serve patients with professional theoretical knowledge and rich clinical experience in a spirit of extreme seriousness and responsibility. With the concept of humanistic care and professionalism, the department strictly follows the international and domestic guidelines for diagnosing and treating cognitive disorders, pays attention to patients' individual characteristics and requirements, and provides quality medical services to all patients.

"The Headache Department" was established in November 2019 and is the first specialized center in China with primary headaches and related secondary headaches as the principal diagnosis and treatment and clinical research objectives, with a headache specialist clinic, special needs clinic, and headache ward, treating patients with the intractable headache from all over China. It is the first headache research center with a headache ward in China. The headache department gives full play to its advantages, integrates various medical resources, devotes itself to the construction of the disciplinary platform of headache disease, the promotion of treatment technology and related scientific research, and constantly improves the clinical treatment level from the perspective of headache disease as a whole to provide advanced, comprehensive, reasonable and effective high-level medical services for headache disease patients.

With the sincere collaboration and joint efforts of the above eight subspecialty departments, Beijing Tiantan Hospital Neurology Center has gradually become a first-class and internationally renowned neurology center in China. At present, the center has nearly 150 doctors. Among them, three people receive the special allowance of the State Council, one national expert, four people belong to the "Ten Hundred Thousand" project, two people belong to the National Hundred Million Talent Project, two people belong to the "Ten, Hundred, Thousand People Plan," one Beijing Scholar, one Changjiang Yong Scholar, one person received the National Natural Science Foundation Outstanding Young Fund, and one person received National Excellent Youth Science Fund recipient.

Relying on the national platform of the National Clinical Medical Research Center for Neurological Diseases and the National Center for Quality Control of Neurological Diseases, the Neurology Center has been driving the development of its disciplines through research and innovation, guided by the needs of clinical problems. In recent years, the Neurology Center has published 342 SCI papers in the New England Journal of Medicine (NEJM), Journal of the American Medical Association (JAMA), British Medical Journal (BMJ), etc. In addition, it has undertaken 141 projects at the provincial and ministerial level or above, including 86 national projects and 36 national key R&D programs and major special projects. The total funding amounted to more than 24,000,000 Yuan. In 2017 and 2018, we were ranked first in neurology in China Hospital Science and Technology Influence Ranking for two consecutive years.

The Neurology Center of Beijing Tiantan Hospital,  Capital Medical University, will continue to forge ahead and innovate to create a world-class brand of neurological disease diagnosis and treatment and scientific research and provide patients with more high-quality and comprehensive treatment services!

Neurology CenterThe Neurology Center of Beijing Tiantan Hospital, Capital Medical University ("Neurology Center") was established in 1980. After nearly 40 years of unremitting efforts of several generations, the center has been steadily developing. It has more than 300 beds and a daily outpatient volume of almost 1,300, making it one of China's largest and most complete neurology departments. …